Sumitoma Pharma US
Ken Ngo is an accomplished finance professional with extensive experience in corporate financial planning and analysis (FP&A). Currently serving as Associate Director of Corporate FP&A at Sumitomo Pharma America, Ken is responsible for migrating and integrating multiple entities and collaborating with cross-functional teams to ensure operational readiness. Prior experience includes Senior Manager roles at Myovant Sciences and Align Technology, where Ken supported various corporate functions and managed finance teams. A history of working with large budgets and fostering alliances with major pharmaceutical partners highlights Ken's financial acumen. Ken holds a Bachelor’s degree in Business Administration with a focus on Finance from San José State University and an Associates degree from Evergreen Valley College.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.